Characterization of ferroptosis in murine models of hemochromatosis

Hepatology

Volumn 66, Issue 2, 2017, Pages 449-465

  Wang, Hao ^a   An, Peng ^a   Xie, Enjun ^a   Wu, Qian ^a   Fang, Xuexian ^a   Gao, Hong ^a   Zhang, Zhuzhen ^a   Li, Yuzhu ^a   Wang, Xudong ^a   Zhang, Jiaying ^a   Li, Guoli ^a   Yang, Lei ^a   Liu, Wei ^b   Min, Junxia ^a   Wang, Fudi ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; GLUTATHIONE; MALONALDEHYDE; NUCLEAR PROTEIN; PROTEIN; SLC7A11 PROTEIN; UNCLASSIFIED DRUG; FERRIC CITRATE; FERRIC ION; IRON; IRON CHELATING AGENT; MCH1R PROTEIN, MOUSE; SOMATOSTATIN RECEPTOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CELL DEATH; CELL FUNCTION; CELL VIABILITY; CONTROLLED STUDY; FERROPTOSIS; HEMOCHROMATOSIS; IRON METABOLISM; IRON OVERLOAD; IRON THERAPY; LIPID PEROXIDATION; LIVER CELL; LIVER FIBROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; ANALYSIS OF VARIANCE; ANIMAL; APOPTOSIS; CELL CULTURE; CELL SURVIVAL; COMPARATIVE STUDY; DISEASE MODEL; KNOCKOUT MOUSE; MACROPHAGE; MALE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; PROCEDURES; RANDOMIZATION; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FERRIC COMPOUNDS; HEMOCHROMATOSIS; HEPATOCYTES; IRON; IRON CHELATING AGENTS; LIPID PEROXIDATION; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; OXIDATIVE STRESS; RANDOM ALLOCATION; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, SOMATOSTATIN; SENSITIVITY AND SPECIFICITY;

EID: 85019186592     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.29117     Document Type: Article

References (47)

1. Ganz T. Systemic iron homeostasis. Physiol Rev 2013;93:1721-1741.
2. Meynard D, Babitt JL, Lin HY. The liver: conductor of systemic iron balance. Blood 2014;123:168-176.
3. Powell LW, Seckington RC, Deugnier Y. Haemochromatosis. Lancet 2016;388:706-716.
4. Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology 2010;139:393-408.
5. Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 2012;149:1060-1072.
6. Dixon SJ, Stockwell BR. The role of iron and reactive oxygen species in cell death. Nat Chem Biol 2014;10:9-17.
7. Yang WS, Kim KJ, Gaschler MM, Patel M, Shchepinov MS, Stockwell BR. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci USA 2016;113:E4966-E4975.
8. Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 2014;156:317-331.
9. Shimada K, Hayano M, Pagano NC, Stockwell BR. Cell-line selectivity improves the predictive power of pharmacogenomic analyses and helps identify NADPH as biomarker for ferroptosis sensitivity. Cell Chem Biol 2016;23:225-235.
10. Yang WS, Stockwell BR. Ferroptosis: death by lipid peroxidation. Trends Cell Biol 2016;26:165-176.
11. Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol 2014;16:1180-1191.
12. Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R, et al. Activation of the p62–Keap1–NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology 2016;63:173-184.
13. Sun X, Niu X, Chen R, He W, Chen D, Kang R, et al. Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis. Hepatology 2016;64:488-500.
14. Gao M, Monian P, Quadri N, Ramasamy R, Jiang X. Glutaminolysis and transferrin regulate ferroptosis. Mol Cell 2015;59:298-308.
15. Kwon MY, Park E, Lee SJ, Chung SW. Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death. Oncotarget 2015;6:24393-24403.
16. Sato H, Tamba M, Ishii T, Bannai S. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J Biol Chem 1999;274:11455-11458.
17. Deneke SM, Fanburg BL. Regulation of cellular glutathione. Am J Physiol 1989;257:L163-L173.
18. Telorack M, Meyer M, Ingold I, Conrad M, Bloch W, Werner S. A glutathione–Nrf2–thioredoxin cross-talk ensures keratinocyte survival and efficient wound repair. PLoS Genet 2016;12:e1005800.
19. – light subunit reveals a re-entrant loop with substrate-restricted accessibility. J Biol Chem 2004;279:31228-31236.
20. Dixon SJ, Patel DN, Welsch M, Skouta R, Lee ED, Hayano M, et al. Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. Elife 2014;3:e02523.
21. Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature 2015;520:57-62.
22. Wang SJ, Li D, Ou Y, Jiang L, Chen Y, Zhao Y, et al. Acetylation is crucial for p53-mediated ferroptosis and tumor suppression. Cell Rep 2016;17:366-373.
23. Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S, et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab 2005;1:191-200.
24. Huang FW, Pinkus JL, Pinkus GS, Fleming MD, Andrews NC. A mouse model of juvenile hemochromatosis. J Clin Invest 2005;115:2187-2191.
25. Nicolas G, Viatte L, Lou DQ, Bennoun M, Beaumont C, Kahn A, et al. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat Genet 2003;34:97-101.
26. Wang RH, Li C, Xu X, Zheng Y, Xiao C, Zerfas P, et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab 2005;2:399-409.
27. Zhang Z, Zhang F, Guo X, An P, Tao Y, Wang F. Ferroportin1 in hepatocytes and macrophages is required for the efficient mobilization of body iron stores in mice. Hepatology 2012;56:961-971.
28. Zhang Z, Zhang F, An P, Guo X, Shen Y, Tao Y, et al. Ferroportin1 deficiency in mouse macrophages impairs iron homeostasis and inflammatory responses. Blood 2011;118:1912-1922.
29. Sato H, Shiiya A, Kimata M, Maebara K, Tamba M, Sakakura Y, et al. Redox imbalance in cystine/glutamate transporter-deficient mice. J Biol Chem 2005;280:37423-37429.
30. Delima RD, Chua AC, Tirnitz-Parker JE, Gan EK, Croft KD, Graham RM, et al. Disruption of hemochromatosis protein and transferrin receptor 2 causes iron-induced liver injury in mice. Hepatology 2012;56:585-593.
31. Nabeyama A, Kurita A, Asano K, Miyake Y, Yasuda T, Miura I, et al. xCT deficiency accelerates chemically induced tumorigenesis. Proc Natl Acad Sci USA 2010;107:6436-6441.
32. Wang GS, Eriksson LC, Xia L, Olsson J, Stal P. Dietary iron overload inhibits carbon tetrachloride–induced promotion in chemical hepatocarcinogenesis: effects on cell proliferation, apoptosis, and antioxidation. J Hepatol 1999;30:689-698.
33. Lunova M, Goehring C, Kuscuoglu D, Mueller K, Chen Y, Walther P, et al. Hepcidin knockout mice fed with iron-rich diet develop chronic liver injury and liver fibrosis due to lysosomal iron overload. J Hepatol 2014;61:633-641.
34. Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh HJ 3rd, et al. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy 2016;12:1425-1428.
35. Ye P, Mimura J, Okada T, Sato H, Liu T, Maruyama A, et al. Nrf2- and ATF4-dependent upregulation of xCT modulates the sensitivity of T24 bladder carcinoma cells to proteasome inhibition. Mol Cell Biol 2014;34:3421-3434.
36. Antelmann H, Helmann JD. Thiol-based redox switches and gene regulation. Antioxid Redox Signal 2011;14:1049-1063.
37. Yagoda N, von Rechenberg M, Zaganjor E, Bauer AJ, Yang WS, Fridman DJ, et al. RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 2007;447:864-868.
38. Yu Y, Xie Y, Cao L, Yang L, Yang M, Lotze MT, et al. The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Mol Cell Oncol 2015;2:e1054549.
39. Gao M, Monian P, Pan Q, Zhang W, Xiang J, Jiang X. Ferroptosis is an autophagic cell death process. Cell Res 2016;26:1021-1032.
40. Mizushima N, Yoshimori T. How to interpret LC3 immunoblotting. Autophagy 2007;3:542-545.
41. Linkermann A, Skouta R, Himmerkus N, Mulay SR, Dewitz C, De Zen F, et al. Synchronized renal tubular cell death involves ferroptosis. Proc Natl Acad Sci USA 2014;111:16836-16841.
42. + interactions with the neutral amino acid transporter ASCT1. J Biol Chem 2014;289:17468-17479.
43. Song H, Her AS, Raso F, Zhen Z, Huo Y, Liu P. Cysteine oxidation reactions catalyzed by a mononuclear non-heme iron enzyme (OvoA) in ovothiol biosynthesis. Org Lett 2014;16:2122-2125.
44. Nahon P, Sutton A, Pessayre D, Rufat P, Charnaux N, Trinchet JC, et al. Do genetic variations in antioxidant enzymes influence the course of hereditary hemochromatosis? Antioxid Redox Signal 2011;15:31-38.
45. Kagan VE, Mao G, Qu F, Angeli JP, Doll S, Croix CS, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol 2017;13:81-90.
46. Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol 2017;13:91-98.
47. Timmerman LA, Holton T, Yuneva M, Louie RJ, Padro M, Daemen A, et al. Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target. Cancer Cell 2013;24:450-465.